alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 75, Number 168 (Tuesday, August 31, 2010)]
[Notices]
[Page 53271]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-21559]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

International Trade Administration


Application(s) for Duty-Free Entry of Scientific Instruments

Pursuant to Section 6(c) of the Educational, Scientific and Cultural 
Materials Importation Act of 1966 (Pub. L. 89-651, as amended by Pub. 
L. 106-36; 80 Stat. 897; 15 CFR part 301), we invite comments on the 
question of whether instruments of equivalent scientific value, for the 
purposes for which the instruments shown below are intended to be used, 
are being manufactured in the United States.
    Comments must comply with 15 CFR 301.5(a)(3) and (4) of the 
regulations and be postmarked on or before September 20, 2010. Address 
written comments to Statutory Import Programs Staff, Room 3720, U.S. 
Department of Commerce, Washington, D.C. 20230. Applications may be 
examined between 8:30 A.M. and 5:00 P.M. at the U.S. Department of 
Commerce in Room 3720.
    Docket Number: 10-022. Applicant: Virginia Commonwealth University, 
School of Medicine, Department of Physiology & Biophysics, 1101 East 
Marshall Street, P.O. Box 980551, Richmond, VA 23298-0551. Instrument: 
Electron Microscope. Manufacturer: FEI Company, The Netherlands. 
Intended Use: The instrument will be used to investigate the three 
dimensional structure of biological macromolecules, which will be 
observed under cryogenic conditions. Justification for Duty-Free Entry: 
There are no instruments of the same general category manufactured in 
the United States. Application accepted by Commissioner of Customs: 
August 3, 2010.

    Dated: August 24, 2010.
Gregory W. Campbell,
Acting Director, IA Subsidies Enforcement Office.
[FR Doc. 2010-21559 Filed 8-30-10; 8:45 am]
BILLING CODE 3510-DS-S
----

EXHIBIT 32.a

CERTIFICATION PURSUANT TO

18 U.S.C. 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Black Gardenia Corp. (the "Company")on Form 10-KSB for the period ended December 31, 2003, as filed with theSecurities and Exchange Commission on the date hereof (the "Report"), I, HarryMiller, in my capacity as Chief Executive Officer, Chief Financial Officer ofthe Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section906 of the Sarbanes-Oxley Act of 2002, that:

- The Report fully complies with the requirements of Section 13(a) or 15(d)  of the Securities Exchange Act of 1934; and
- The information contained in the Report fairly presents, in all material  respects, the financial condition and results of operations of the Company.

 

| Date: April 14, 2004 | /s/ Harry Miller

_______________________    Harry Miller, C.E.O and C.F.O |
|----------------------|----------------------------------------------------------------------------|
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[S. 2214 Introduced in Senate (IS)]

113th CONGRESS
  2d Session
                                S. 2214

       To prevent a taxpayer bailout of health insurance issuers.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 7, 2014

   Mr. Rubio introduced the following bill; which was read twice and 
  referred to the Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL

 
       To prevent a taxpayer bailout of health insurance issuers.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Obamacare Taxpayer Bailout 
Protection Act''.

SEC. 2. PREVENTION OF BAILOUT OF HEALTH INSURANCE ISSUERS.

    Section 1342 of the Patient Protection and Affordable Care Act (42 
U.S.C. 18062) is amended by adding at the end the following:
    ``(d) Ensuring Budget Neutrality.--In implementing this section, 
the Secretary shall ensure that payments out and payments in under 
paragraphs (1) and (2) of subsection (b) are provided for in amounts 
that the Secretary determines are necessary to reduce to zero the cost 
(as defined in section 502 of the Federal Credit Reform Act of 1990 (2 
U.S.C. 661a)) to the Federal Government of carrying out the program 
under this section.''.
                                 <all>
```
[Federal Register Volume 75, Number 166 (Friday, August 27, 2010)]
[Notices]
[Page 52716]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-21370]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE


Environmental Technologies Trade Advisory Committee (ETTAC)

AGENCY: International Trade Administration, U.S. Department of 
Commerce.

ACTION: Notice of open meeting.

-----------------------------------------------------------------------

SUMMARY: The Environmental Technologies Trade Advisory Committee 
(ETTAC) will hold its quarterly meeting to discuss environmental 
technologies industry competitiveness issues, the National Export 
Initiative, and general Committee administrative items.

DATES:  September 21, 2010.

ADDRESSES: U.S. Department of Commerce, 1401 Constitution Avenue, NW., 
Washington, DC 20230, Room 6029.

FOR FURTHER INFORMATION CONTACT: Ellen Bohon, Office of Energy and 
Environmental Technologies Industries (OEEI), International Trade 
Administration, U.S. Department of Commerce at (202) 482-0359. This 
meeting is physically accessible to people with disabilities. Requests 
for sign language interpretation or other auxiliary aids should be 
directed to OEEI at (202) 482-5225.

SUPPLEMENTARY INFORMATION: The meeting will take place from 9 a.m. to 
3:30 p.m. This meeting is open to the public and time will be permitted 
for public comment from 3-3:30 p.m. Written comments concerning ETTAC 
affairs are welcome any time before or after the meeting. Minutes will 
be available within 30 days of this meeting.
    The ETTAC is mandated by Public Law 103-392. It was created to 
advise the U.S. government on environmental trade policies and 
programs, and to help it to focus its resources on increasing the 
exports of the U.S. environmental industry. ETTAC operates as an 
advisory committee to the Secretary of Commerce and the Trade Promotion 
Coordinating Committee (TPCC). ETTAC was originally chartered in May of 
1994. It was most recently re-chartered until September 2010.

    Dated: August 23, 2010.
Edward A. O'Malley,
Director, Office of Energy and Environmental Industries.
[FR Doc. 2010-21370 Filed 8-26-10; 8:45 am]
BILLING CODE 3510-DR-P
#### Mary Lou HOUSE, Appellant, v. Monty Dale HOUSE, Appellee.

Court of Appeals of Kentucky.

May 17, 1974.

Charles J. Kamuf, Rummage, Kamuf & Yewell, Owensboro, for appellant.

Harold Wayne Newton, Hawesville, for appellee.

Memorandum Opinion of the Court by

Justice STEINFELD,

Affirming.*
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[S. 2195 Engrossed in Senate (ES)]

113th CONGRESS
  2d Session
                                S. 2195

_______________________________________________________________________

                                 AN ACT

 
  To deny admission to the United States to any representative to the 
  United Nations who has been found to have been engaged in espionage 
activities or a terrorist activity against the United States and poses 
         a threat to United States national security interests.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. VISA LIMITATION FOR CERTAIN REPRESENTATIVES TO THE UNITED 
              NATIONS.

    Section 407(a) of the Foreign Relations Authorization Act, Fiscal 
Years 1990 and 1991 (8 U.S.C. 1102 note) is amended--
            (1) by striking ``such individual has been found to have 
        been engaged in espionage activities'' and inserting the 
        following: ``such individual--
            ``(1) has been found to have been engaged in espionage 
        activities or a terrorist activity (as defined in section 
        212(a)(3)(B)(iii) of the Immigration and Nationality Act (8 
        U.S.C. 1182(a)(3)(B)(iii)))''; and
            (2) by striking ``allies and may pose'' and inserting the 
        following: ``allies; and
            ``(2) may pose''.

            Passed the Senate April 7, 2014.

            Attest:

                                                             Secretary.
113th CONGRESS

  2d Session

                                S. 2195

_______________________________________________________________________

                                 AN ACT

  To deny admission to the United States to any representative to the 
  United Nations who has been found to have been engaged in espionage 
activities or a terrorist activity against the United States and poses 
         a threat to United States national security interests.
```
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO SECTION 906 OF  THE SARBANES-OXLEY ACT OF 2002

In connection with this annual report of Safety Insurance Group, Inc. (the "Company") on Form 10-K for the
period ending December 31, 2009, as filed with the United States Securities and Exchange Commission on the date hereof (the "Report"), I, David F. Brussard, President, Chief Executive
Officer and Chairman of the Board of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my
knowledge:



/s/ DAVID F. BRUSSARD David F. Brussard President, Chief Executive Officer and
Chairman of the Board
(Principal Executive Officer)March 15, 2010


---



QuickLinks
Exhibit 10.29

 

2014 CASH INCENTIVE PLAN

 

Purpose:

 

The terms of the 2014 Cash Incentive Plan (the “Plan”) have been established to reward the executives and other employees of Rigel Pharmaceuticals, Inc. (the “Company”) for assisting the Company in achieving its operational goals through exemplary performance. Under the Plan, cash bonuses, if any, will be based on both the achievement of corporate goals and a review of personal performance, which is determined at the discretion of the Compensation Committee of the Board of Directors (the “Compensation Committee”) and/or the Board of Directors (the “Board”).  The overarching intent in setting and achieving the goals is to build long-term shareholder value.

 

Determination of 2014 Cash Bonuses:

 

Target bonuses for participants in the Plan will range from 5% to 60% of such recipient’s 2014 base salary, with a range for executives of 40% to 60% of such executive’s 2014 base salary. The maximum bonus that a participant will be eligible to receive is 120% of such participant’s 2014 base salary and in no event will a bonus be paid later than March 15 of the year following the year in which the bonus was earned. The objective Company performance goals for each participant will be based on meeting certain goals with respect to the Company’s financial and operational performance, expanding the clinical development pipeline (weighted at 10%), advancing multiple product candidates in multiple indications in clinical development (weighted at 30%), initiating and advancing a late-stage clinical candidate (weighted at 25%), obtaining positive efficacy results in a clinical study (weighted at 25%), and maintaining a viable cash position for the Company at December 31, 2014 (weighted at 10%), as well as other Company performance goals to be determined by the Compensation Committee, including consideration of shareholder return compared to peer companies. The Board and Compensation Committee reserve the right to modify these goals and criteria at any time or to grant bonuses to the participants even if the performance goals are not met, as well as to withhold bonuses if a minimum threshold of 40% of the goals are not met.
* Pursuant to 5 TH C IR . R. 47.5, the court has determined

that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 98-11015 Summary Calendar

UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus DOUGLAS RAY DUNKINS, JR., Defendant-Appellant.

- - - - - - - - - - Appeal from the United States District Court for the Northern District of Texas USDC No. 4:97-CV-302-Y

- - - - - - - - - - August 4, 1999 Before HIGGINBOTHAM, JONES, and DENNIS, Circuit Judges. PER CURIAM: * Douglas Ray Dunkins, Jr., federal prisoner # 22619-077, appeals from the denial of his motion for reduction of sentence pursuant to 28 U.S.C. § 3582. He also moves for a certificate of appealability (COA) in order to appeal the denial of his 28 U.S.C. § 2255 motion. Dunkins’ challenge to the district court’s rationale for denying the § 3582 motion is without merit. The district court did not abuse its discretion by denying the motion. See UnitedNo. 98-11015 -2- States v. Gonzalez-Balderas , 105 F.3d 981, 982 (5th Cir. 1997). Accordingly, the judgment of the district court is AFFIRMED. Dunkins raises the following in seeking a COA:1) several grounds in support of an ineffective-assistance-ofcounsel claim; and 2) a violation of Brady v. Maryland , 373 U.S. 83 (1963). Dunkins fails to make a substantial showing of the denial of a constitutional right. See 2253(c)(2). His request for a COA is DENIED. AFFIRMED. COA DENIED.
#### Harold M. Furber, Plaintiff, *v.*Helen V. W. Sidell et al., Defendants.

County Court, Wayne County,

June 3, 1957.

*Philip L. Zenner*for defendants.

*Carl L. Katz*for plaintiff.

*555Jambs D. Hurley, J.

This is a motion made by the defendants for a jury trial of the issues.

In this action to foreclose a mortgage on real property, defenses of usury and of payment are raised by the answer.

While courts have granted jury trials of the question of usury pleaded as a defense in a mortgage foreclosure action, I am satisfied that a jury trial of such an issue is not a matter of right, but rests in the discretion of the court. *(New Orleans Gas Light and Banking Co.*v. *Dudley,*8 Paige, ch. 451; *Apel*v. *O’Connor,*39 Hun 482.)

This motion, made pursuant to section 429 of the Civil Practice Act, should have been made pursuant to section 430 of the Civil Practice Act. The court will consider this motion as having been made pursuant to the correct section.

Where the right to a jury trial is discretionary, motion therefor must be made within 20 days after issue joined. (Rules Civ. Prac., rule 157.) The motion has not been timely made here. No excuse for the delay has been shown in the moving papers.

While some older cases have granted an application for a jury trial made after the limitation period provided in rule 157 under exceptional circumstances, the modern practice seems to be to the contrary.

This application for jury trial must be denied. *(Ellensohn*v. *Keyes,*6 App. Div. 601; *Arnot*v. *Nevins,*44 App. Div. 61; *Moss*v. *Burnham,*50 App. Div. 301; *McGraw*v. *Bank of Richmondville,*238 App. Div. 437; *Auerback*v. *Chase Nat. Bank,*251 App. Div. 543; *Elmira Savings & Loan Assn.*v. *Spring,*261 App. Div. 1034; *People*v. *System Properties,*44 N. Y. S. 2d 835; *Gramling*v. *Gramling,*80 N. Y. S. 2d 387; *Heyman*v. *Felice,*199 Misc. 619.)

Prepare order accordingly.
Exhibit 12.1  Certification  I, Kevin Hanson, Chief Executive Officer, certify that:  1. I have reviewed this Annual Report on Form 20-F of Brockton Capital Corp.;  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Annual Report;  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;  4. The companys other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d -15(f)) for the company and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Evaluated the effectiveness of the companys disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (c) Evaluated the effectiveness of the company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the companys internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the companys internal control over financial reporting; and  5. The companys other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the companys auditors and the audit committee of the companys board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the companys ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the companys internal control over financial reporting.  Date: September 6, 2006  Kevin Hanson___________ Chief Executive Officer  1
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
This  schedule  contains  summary  financial   information  extracted  from  the
Company's  Form 10-Q for the quarter  ended January 31, 1997 and is qualified in
its entirety by reference to such financial statements.
</LEGEND>
       
<S>                                          <C>
<PERIOD-TYPE>                                9-MOS
<FISCAL-YEAR-END>                                          APR-30-1997
<PERIOD-END>                                               JAN-31-1997
<CASH>                                                         556,028
<SECURITIES>                                                         0
<RECEIVABLES>                                               16,760,891
<ALLOWANCES>                                                         0
<INVENTORY>                                                  5,580,788
<CURRENT-ASSETS>                                            24,374,905
<PP&E>                                                       7,379,334
<DEPRECIATION>                                                       0
<TOTAL-ASSETS>                                              34,696,908
<CURRENT-LIABILITIES>                                       28,477,639
<BONDS>                                                              0
<PREFERRED-MANDATORY>                                                0
<PREFERRED>                                                        150
<COMMON>                                                        20,752
<OTHER-SE>                                                   1,615,499
<TOTAL-LIABILITY-AND-EQUITY>                                34,696,908
<SALES>                                                     73,965,113
<TOTAL-REVENUES>                                            73,965,113
<CGS>                                                       49,858,135
<TOTAL-COSTS>                                               73,428,632
<OTHER-EXPENSES>                                                     0
<LOSS-PROVISION>                                                     0
<INTEREST-EXPENSE>                                           1,067,211
<INCOME-PRETAX>                                               (530,730)
<INCOME-TAX>                                                   313,687
<INCOME-CONTINUING>                                           (844,417)
<DISCONTINUED>                                                       0
<EXTRAORDINARY>                                                      0
<CHANGES>                                                            0
<NET-INCOME>                                                  (844,417)
<EPS-PRIMARY>                                                     (.04)
<EPS-DILUTED>                                                        0
        

</TABLE>
Exhibit 13.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

In connection
with the Annual Report on Form 20-F of Gold Fields Limited (the Company) for the period ended December 31, 2016 as filed with the Securities and Exchange Commission on the date hereof
(the Report), I, Nicholas J. Holland, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



|1 | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|- | ---------------------------------------------------------------------------------------------------------------------



|2 | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                       
|-----------------------
|Date: April 5, 2017    
|                       
|/s/ Nicholas J. Holland
|Nicholas J. Holland    
|Chief Executive Officer
# Fourth Court of Appeals

San Antonio, Texas

May 21, 2015

N o. 04

- 14

- 00668

- CV

WEST 17TH RESOURCES, LLC, Pamela Mika Wolf, and Thomas Mika,

Appellant s

v.

Lucian A. PAWELEK and Carleen J. Pawelek,

Appellee s

From the 81st Judicial District Court, Karnes County, Texas

Trial Court No. 13

- 04

- 00087

- CVK

Honorable Donna S. Rayes, Judge Presiding



### O R D E R

The Appellee’s Opposed 3 rd and Final Motion for Extension of Time to File Brief is

hereby GRANTED.

_________________________________ Marialyn Barnard, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said

court on this 21st day of May, 2015

.

___________________________________ Keith E. Hottle

Clerk of Court